Related Experiment Video
Updated: Jan 18, 2026

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
Published on: November 24, 2021
Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Secukinumab: Dose Exploration in Pediatric Patients
Liu Zhiwei1,2, Wang Wenhui1,2, Chen Tao1,2
1Anhui Provincial Center for Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.
Abstract:
Secukinumab has been widely applied in adults for the treatment of plaque psoriasis and psoriatic arthritis. However, there remains a knowledge gap in the dosing of secukinumab for pediatric patients with plaque psoriasis. This study aims to investigate the dosing regimen for pediatric patients aged 2 years and older. A physiologically based pharmacokinetic model for secukinumab was developed and validated in adult patients. Based on this model, two additional observation compartments for total interleukin-17A (IL-17A) and skin free IL-17A were incorporated to evaluate the inhibition of secukinumab on its targets. Ultimately, this model was extrapolated to pediatric patients. The model precisely captured the pharmacokinetic profiles and serum total IL-17A levels observed in different studies, encompassing various dosing schedules and formulations. Pediatric patients were stratified by weight, and the model incorporated age-related developmental factors. Using the inhibition of skin free IL-17A during steady-state treatment as a benchmark for a 300 mg adult dose indicates that pediatric patients weighing less than 25 kg require 75 mg, those weighing between 25 and 50 kg require 150 mg, and patients weighing more than 50 kg require 225 mg to achieve similar levels of inhibition. This conclusion provides new ideas for flexible medication use in pediatric patients with psoriasis.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
11:39The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...